Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.

× No keyword cloud information.

22 in total

1. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.

Authors: T Ochiai; K Nakajima; M Nagata; S Hori; T Asano; K Isono
Journal: Transplantation Date: 1987-12 Impact factor: 4.939

2. Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

Authors: N Murase; S Todo; P H Lee; H S Lai; F Chapman; M A Nalesnik; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

3. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

Authors: S Todo; A J Demetris; Y Ueda; O Imventarza; K Okuda; A Casavilla; S Cemaj; A Ghalab; V Mazzaferro; B S Rhoe
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

4. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

Authors: H Tanaka; A Kuroda; H Marusawa; M Hashimoto; H Hatanaka; T Kino; T Goto; M Okuhara
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

5. T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors: S Gillis; M M Ferm; W Ou; K A Smith
Journal: J Immunol Date: 1978-06 Impact factor: 5.422

6. Effect of cyclosporin A on lymphocyte activation by the calcium ionophore A23187.

Authors: J E Kay; C R Benzie; A F Borghetti
Journal: Immunology Date: 1983-11 Impact factor: 7.397

7. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors: J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal: Nature Date: 1989-10-26 Impact factor: 49.962

8. IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.

Authors: A Zeevi; R Duquesnoy; G Eiras; S Todo; L Makowka; T Starzl
Journal: Surg Res Commun Date: 1987

9. Mechanisms of T cell activation by the calcium ionophore ionomycin.

Authors: T Chatila; L Silverman; R Miller; R Geha
Journal: J Immunol Date: 1989-08-15 Impact factor: 5.422

10. Evidence for an interleukin-independent pathway for human lymphocyte activation.

Authors: G A Koretzky; R P Daniele; W C Greene; P C Nowell
Journal: Proc Natl Acad Sci U S A Date: 1983-06 Impact factor: 11.205

4 in total

1. The effect of cyclosporin A administration on bone metabolism in the rat evaluated by biochemical markers.

Authors: K Kawana; M Takahashi; K Kushida; H Hoshino; S Sakata; T Inoue
Journal: J Endocrinol Invest Date: 1996-09 Impact factor: 4.256

2. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.

Authors: M L Jordan; R Shapiro; C A Vivas; V P Scantlebury; F S Darras; G Carrieri; J McCauley; A J Demetris; P Randhawa; C Jensen
Journal: Transplant Proc Date: 1993-02 Impact factor: 1.066

Review 3. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors: D H Peters; A Fitton; G L Plosker; D Faulds
Journal: Drugs Date: 1993-10 Impact factor: 9.546

4. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.

Authors: M L Jordan; R Shapiro; C A Vivas; V P Scantlebury; P Rhandhawa; G Carrieri; J McCauley; A J Demetris; A Tzakis; J J Fung
Journal: Transplantation Date: 1994-03-27 Impact factor: 4.939

4 in total